Beat Künzli

CD39 deletion exacerbates experimental murine colitis and human polymorphisms increase susceptibility to inflammatory bowel disease

David J. Friedman, Beat Künzli, Yousif I. A-Rahim et al. · Proceedings of the National Academy of Sciences · 2009 · 283 citations · Full text

Life Sciences, Genetics, Molecular Genetics +17

Inhibition of Heme Oxygenase-1 Increases Responsiveness of Pancreatic Cancer Cells to Anticancer Treatment

Pascal O. Berberat, Žilvinas Dambrauskas, Antanas Gulbinas et al. · Clinical Cancer Research · 2005 · 264 citations

Medicine, Cell Biology, Oncology +14

Upregulation of CD39/NTPDases and P2 receptors in human pancreatic disease

Beat Künzli, Pascal O. Berberat, Thomas Giese et al. · American Journal of Physiology-Gastrointestinal and Liver Physiology · 2006 · 160 citations

Medicine, Molecular Biology, Pharmacology +16

Role of Mononuclear Cells and Inflammatory Cytokines in Pancreatic Cancer-Related Cachexia

Marc E. Martignoni, P. Kunze, Wulf Hildebrandt et al. · Clinical Cancer Research · 2005 · 155 citations · Full text

Medicine, Immunology, Oncology +15

Impact of CD39 and purinergic signalling on the growth and metastasis of colorectal cancer

Beat Künzli, Maria-Isabell Bernlochner, Stephan Rath et al. · Purinergic Signalling · 2011 · 124 citations · Full text

Medicine, Oncology, Pharmacology +14